Abstract
The chemokine superfamily consists of small, basic, heparin-binding proteins that play a pivotal role in basal trafficking as well as in activation and recruitment of leukocytes from the circulation to sites of inflammation. The chemokines are a subset of the cytokine family and are distinguished from other cytokines in that they activate seven-transmembrane (7TM) G protein-coupled receptors. They are a large family, with approximately 50 members identified to date, and for which 19 receptors have been described. The chemokine family is divided structurally into four subfamilies CXC, CC, CX3C and C, based on the position of the amino terminal cysteine residues. The majority of chemokines fall into the CXC or CC groups (also referred to as α and β subclasses respectively), and hence have been the most extensively studied. The known chemo-kine/receptor pairs are depicted in Fig. 1, which also indicates a second division based on the recent advances in chemokine biology—chemokines are either expressed constitutively and control basal trafficking or homing, or are inducible, and are involved in inflammation. Chemokines were generally named according to the function that was identified such as monocyte chemoattractant protein (MCP) or neutrophil activating peptide (NAP) but since many chemokines were concomitantly identified in more than one laboratory, a single sequence was attributed more than one name. Therefore a systematic nomenclature was recently adopted (Zlotnik and Yoshie 2000) and both common and systematic names are shown in Fig. 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL (2001) The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 166:552–558
Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160:624–633
Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, Kretzler M, Strutz F, Mack M, Grone HJ, Onuffer J, Horuk R, Nelson PJ, Schlondorff D (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109:251–259
Appay V, Brown A, Cribbes S, Randle E, Czaplewski LG (1999) Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants. J Biol Chem 274:27505–27512
Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B, Baggiolini M (1996) HIV blocked by chemokine antagonist. Nature 383:400
Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y, Shiraishi M, Aramaki Y, Okonogi K, Ogawa Y, Meguro K, Fujino M (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 96:5698–5703
Balashov KE, Rottman JB, Weiner HL, Hancock WW (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 96:6873–6878
Barnes DA, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, Horuk R, Perez HD (1998) Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 101:2910–2919
Beck LA, Dalke S, Leiferman KM, Bickel CA, Hamilton R, Rosen H, Bochner BS, Schleimer RP (1997) Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. J Immunol 159:2962–2972
Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3–S16. 1997
Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, Wymann MP (1998) Bifurcation of lipid and protein kinase signals of PBKgamma to the protein kinases PKB and MAPK. Science 282:293–296
Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV, Jr., Broxmeyer HE, Charo IF (1997) Impaired monocyte migration and reduced type 1 (Thl) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552–2561
Bridgeman A, Stevenson PG, Simas JP, Efstathiou S (2001) A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J Exp Med 194:301–312
Butcher EC (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033–1036
Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, Feng L (1998) In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193–198
Cinamon G, Shinder V, Alon R (2001) Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2:515–522
Clark-Lewis I, Schumacher C, Baggiolini M, Moser B (1991) Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil Chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 266:23128–23134
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors produced by CD8+ T cells. Science 270:1811–1815
Colditz I, Zwahlen R, Dewald B, Baggiolini M (1989) In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 134:755–760
Colditz IG, Zwahlen RD, Baggiolini M (1990) Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukoc Biol 48:129–137
Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K (1998) Interferon-inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3. J Exp Med 187:2009–2021
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583–1585
Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, Hipkin, RW. (2001) Human interferon-inducible 10-kDa protein and human interferon-inducipble T cell alpha chemoattractant are allotopic ligands for human CXCR3: Differential binding to receptor states. Mol Pharmacol. 59:707–715
Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763–767
Devalaraja MN, Richmond A (1999) Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol Sci 20:151–156
Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 4:72–77
Dragic T, Trkola A, Thompson DA, Cormier EG, Kajumo FA, Maxwell E, Lin SW, Ying W, Smith SO, Sakmar TP, Moore JP (2000) A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci U S A 97:5639–5644
Dustin ML, Springer TA (1991) Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9:27–66
Evans GF, Snyder YM, Butler LD, Zuckerman SH (1989) Differential expression of inter-leukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279–290
Farber JM (1990) A Macrophage mRNA Selectively Induced by {gamma}-lnterferon Encodes a Member of the Platelet Factor 4 Family of Cytokines. PNAS 87:5238–5242
Fine JS, Jackson JV, Rojas-Triana A, Bober LA (2000) Evaluation of chemokine- and phlogistin-mediated leukocyte Chemotaxis using an in vivo sponge model. Inflammation 24:331–346
Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037–1047
Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microen-vironments in secondary lymphoid organs. Cell 99:23–33
Foster SJ, Aked DM, Schroder JM, Christophers E (1989) Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology 67:181–183
Foxman EF, Campbell JJ, Butcher EC (1997) Multistep navigation and the combinatorial control of leukocyte Chemotaxis. J Cell Biol 139:1349–1360
Gether U, Kobilka BK (1998) G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273:17979–17982
Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A (1993) Endotoxin-induced organ injury. Crit Care Med 21:S19–S24
Gillespie RD, Dolan MC, Piesman J, Titus RG (2001) Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J Immunol 166:4319–4326
Gong JH, Clark-Lewis I (1995) Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 181:631–640
Gong JH, Uguccioni M, Dewald B, Baggiolini M, Clark-Lewis I (1996) RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271:10521–10527
Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773–778
Grone HJ, Weber C, Weber KC, Grone EF, Rabelink T, Klier CM, Wells TC, Proudfoot AE, Schlondorff D, Nelson PJ (1999) Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEBJ 13:1371–1383
Gunn MD, Nelken NA, Liao X, Williams LT (1997) Monocyte chemoattractant protein-1 is sufficient for the Chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158:376–383
Hajnicka V, Kocakova P, Slavikova M, Slovak M, Gasperik J, Fuchsberger N, Nuttall PA (2001) Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol 23:483–489
Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G (1998) Direct stimulation of the guanine nucleotide exchange activity of p115 Rho-GEF by Galpha13. Science 280:2112–2114
Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP (2000) Central role for G protein-coupled phosphoinosi-tide 3-kinase gamma in inflammation. Science 287:1049–1053
Hisada T, Hellewell PG, Teixeira MM, Malm MG, Salmon M, Huang TJ, Chung KF (1999) alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. Am J Respir Cell Mol Biol 20:992–1000
Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8:157–165
Horuk R, Clayberger C, Krensky AM, Wang Z, Grone HJ, Weber C, Weber KS, Nelson PJ, May K, Rosser M, Dunning L, Liang M, Buckman B, Ghannam A, Ng HP, Islam I, Bauman JG, Wei GP, Monahan S, Xu W, Snider RM, Morrissey MM, Hesselgesser J, Perez HD (2001) A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem 276:4199–4204
Hosaka S, Akahoshi T, Wada C, Kondo H (1994) Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 97:451–457
Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM (2001) Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713–726
Jiang H, Kuang Y, Wu Y, Xie W, Simon MI, Wu D (1997) Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proc Natl Acad Sci U S A 94:7971–7975
Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:881–887
Karpus WJ, Kennedy KJ (1997) MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Thl/Th2 lymphocyte differentiation. J Leukoc Biol 62:681–687
Katanaev VL (2001) Signal transduction in neutrophil Chemotaxis. Biochemistry 66:351–368
Katschke KJ, Jr., Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44:1022–1032
Kaufmann A, Salentin R, Gemsa D, Sprenger H (2001) Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol 69:248–252
Kim KS, Rajarathnam K, Clark-Lewis I, Sykes BD (1996) Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett 395:277–282
Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, Clarklewis I, Wells TNC, Schwartz TW (1997) A broad-spectrum chemokine antagonist encoded by kaposis sarcoma- associated herpesvirus. Science 277:1656–1659
Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90:772–779
Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM (1994) Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 93:921–928
Koch AE, Kunkel SL, Shah MR, Fu R, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM (1995) Macrophage inflammatory protein-1 beta: a C-C chemokine in osteoarthritis. Clin Immunol Immunopathol 77:307–314
Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, Vogel SN (1999) Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163:1537–1544
Kurihara T, Warr G, Loy J, Bravo R (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757–1762
Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94:12053–12058
Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, Kelvin D, McFadden G (1997) The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol 71:4356–4363
Lalani AS, McFadden G (1997) Secreted poxvirus chemokine binding proteins. J Leukoc Biol 62:570–576
Laurence JS, Blanpain C, Burgner JW, Parmentier M, Liwang PJ (2000) CC chemokine MIP-1 beta can function as a monomer and depends on Phel3 for receptor binding.Biochemistry 39:3401–3409
Leonard EJ, Yoshimura T, Tanaka S, Raffeld M (1991) Neutrophil recruitment by intrader-mally injected neutrophil attractant/activation protein-1. J Invest Dermatol 96:690–694
Liang M, Mallari C, Rosser M, Ng HP, May K, Monahan S, Bauman JG, Islam I, Ghannam A, Buckman B, Shaw K, Wei GP, Xu W, Zhao Z, Ho E, Shen J, Oanh H, Subramanyam B, Vergona R, Taub D, Dunning L, Harvey S, Snider RM, Hesselgesser J, Morrissey MM, Perez HD (2000) Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem 275:19000–19008
Liu L, Lalani A, Dai E, Seet B, Macauley C, Singh R, Fan L, McFadden G, Lucas A (2000) The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest 105:1613–1621
Lloyd CM, Dorf ME, Proudfoot A, Salant DJ, Gutierrez-Ramos JC (1997) Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 62:676–680
Lusso P (2000) Chemokines and viruses: the dearest enemies. Virology 273:228–240
Luster AD, Weinshank RL, Feinman R, Ravetch JV (1988) Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J Biol Chem 263:12036–12043
Luttichau HR, Stine J, Boesen TP, Johnsen AH, Chantry D, Gerstoft J, Schwartz TW (2000) A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med 191:171–180
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in C. Proc Natl Acad Sci U S A 95:9448–9453
Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, Bruhl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlondorff D (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 166:4697–4704
Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TNC, Schlondorff D, Proudfoot AEI (1998) Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187:1215–1224
Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045
McFadden G, Murphy PM (2000) Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr Opin Microbiol 3:371–378
McMahon EJ, Cook DN, Suzuki K, Matsushima GK (2001) Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167:2964–2971
Mellado M, Rodriguez-Frade JM, Aragay A, del Real G, Martin AM, Vila-Coro AJ, Serrano A, Mayor F, Jr., Martinez A (1998) The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J Immunol 161:805–813
Mellado M, Rodriguez-Frade JM, Manes S, Martinez A (2001) Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19:397–421
Meurer R, Van Riper G, Feeney W, Cunningham P, Hora D, Jr., Springer MS, Maclntyre DE, Rosen H (1993) Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med 178:1913–1921
Mishell B.B. (1980) Preparation of Mouse Cell Suspensions. In: Mishell B.B., Shiigi S.M. (eds) Selected Methods In Cellular Immunology. W.H. Freeman and Company, New York, pp. 6–8
Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123–128
Murphy PM (1996) Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 7:47–64
Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638
Nelken NA, Coughlin SR, Gordon D, Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121–1127
Ogata H, Takeya M, Yoshimura T, Takagi K, Takahashi K (1997) The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol 182:106–114
Oppermann M, Mack M, Proudfoot AE, Olbrich H (1999) Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274:8875–8885
Paavola CD, Hemmerich S, Grunberger D, Polsky I, Bloom A, Freedman R, Mulkins M, Bhakta S, McCarley D, Wiesent L, Wong B, Jarnagin K, Handel TM (1998) Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem 273:33157–33165
Parent CA, Devreotes PN (1999) A cell’s sense of direction. Science 284:765–770
Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573–578
Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN (1997) Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 57:117–120
Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, Scadden DT (2000) Active movement of T cells away from a chemokine. Nat Med 6:543–548
Proudfoot AE, Buser R, Borlat F, Alouani S, Soler D, Offord RE, Schroder JM, Power CA, Wells TN (1999) Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem 274:32478–32485
Proudfoot AEI, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, Offord RE, Wells TNC (1996) Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 271:2599–2603
Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I (1994) Neutrophil activation by monomeric interleukin-8. Science 264:90–92
Rampart M, Van Damme J, Zonnekeyn L, Herman AG (1989) Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 135:21–25
Rani MR, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM (1996) Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 271:22878–22884
Ransohoff RM, Tani M (1998) Do chemokines mediate leukocyte recruitment in posttraumatic CNS inflammation? Trends Neurosci 21:154–159
Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR (1993) Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268:5834–5839
Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC (2001) CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194:1541–1547
Rodrick ML, Lamster IB, Sonis ST, Pender SG, Kolodkin AB, Fitzgerald JE, Wilson RE (1982) Effects of supernatants of polymorphonuclear neutrophils recruited by different inflammatory substances on mitogen responses of lymphocytes. Inflammation 6:1–11
Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, Jose PJ, Williams TJ, Gerard CJ, Ponath PD (1998) Cloning and characterization of the guinea pig eosinophil eo-taxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol 161:6139–6147
Sabroe I, Peck MJ, Van Keulen BJ, Jorritsma A, Simmons G, Clapham PR, Williams TJ, Pease JE (2000) A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J Biol Chem 275:25985–25992
Sakanashi Y, Takeya M, Yoshimura T, Feng L, Morioka T, Takahashi K (1994) Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J Leukoc Biol 56:741–750
Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumer-oulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722–725
Segerer S, Nelson PJ, Schlondorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11:152–176
Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleu-kin-8. Nature 365:654–657
Sellebjerg F, Madsen HO, Jensen CV, Jensen J, Garred P (2000) CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 102:98–106
Signoret N, Pelchen-Matthews A, Mack M, Proudfoot AEI, Marsh M (2000) Endocytosis and recycling of the HIV coreceptor CCR5. J Cell Biol. 151:1281–1293
Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde, MM, Schwartz TW, Buser R, Wells TNC, Proudfoot AEI (1997) Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276–279
Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807–815
Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425–434
Stine JT, Chantry D, Gray P (1999) Virally encoded chemokines and chemokine receptors: genetic embezzlement of host DNA. Chem Immunol 72:161–180
Streblow DN, Orloff SL, Nelson JA (2001) Do pathogens accelerate atherosclerosis? J Nutr 131:2798S–2804S
Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511–520
Strizki JM, Xu S, Wagner NE, Wojcik L, Liu J, Hou Y, Endres M, Palani A, Shapiro S, Clader JW, Greenlee WJ, Tagat JR, McCombie S, Cox K, Fawzi AB, Chou CC, Pugliese-Sivo C, Davies L, Moreno ME, Ho DD, Trkola A, Stoddart CA, Moore JP, Reyes GR, Baroudy BM (2001) SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A 98:12718–12723
Strunk T, Bubel S, Mascher B, Schlenke P, Kirchner H, Wandinger KP (2000) Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor- alpha-secreting T lymphocytes in multiple sclerosis patients. Ann Neurol 47:269–273
Swensson O, Schubert C, Christophers E, Schroder JM (1991) Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light-and electronmicroscopic study. J Invest Dermatol 96:682–689
Szabo C, Scott GS, Virag L, Egnaczyk G, Salzman AL, Shanley TP, Hasko G (1998) Suppression of macrophage inflammatory protein (MIP)-lalpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 125:379–387
Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsu-shima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591–594
Takami S, Minami M, Nagata I, Namura S, Satoh M (2001) Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1430–1435
Takano K, A1 Mokdad M, Shibata F, Tsuchiya H, Nakagawa H (1999) Rat macrophage inflammatory protein-1alpha, a CC chemokine, acts as a neutrophil chemoattractant in vitro and in vivo. Inflammation 23:411–424
Tran EH, Kuziel WA, Owens T (2000) Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. Eur J Immunol 30:1410–1415
Trebst C, Ransohoff RM (2001) Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Arch Neurol 58:1975–1980
Van Damme J, Proost P, Lenaerts JP, Opdenakker G (1992) Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 176:59–65
Villiger PM, Terkeltaub R, Lotz M (1992) Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 90:488–496
Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE (1998) RANTES expression and contribution to monocyte Chemotaxis in arthritis. Clin Immunol Immunopathol 89:44–53
Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams SA, Walker BD, Pasternack MS, Luster AD (1998) b-Chemokines are released from HIV-1-specific cytolytic granules complexed to potreoglycans. Nature 391:908–911
Weber KS, Grone HJ, Rocken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C (2001) Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol 31:2458–2466
Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, Weber C (1999) Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 29:700–712
Weiss JM, Downie SA, Lyman WD, Berman JW (1998) Astrocyte-derived monocyte-che-moattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J Immunol 161:6896–6903
Wilkinson PC (1998) Assays of leukocyte locomotion and Chemotaxis. J Immunol Methods 216:139–153
Wong M, Fish EN (1998) RANTES and MIP-1alpha activate stats in T cells. J Biol Chem 273:309–314
Yokochi S, Hashimoto H, Ishiwata Y, Shimokawa H, Haino M, Terashima Y, Matsushima K (2001) An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2. J Interferon Cytokine Res 21:389–398
Zhang Y, Rollins BJ (1995) A dominant negative inhibitor indicates that monocyte che-moattractant protein 1 functions as a dimer. Mol Cell Biol 15:4851–4855
Zhou N, Luo Z, Luo J, Liu D, Hall JW, Pomerantz RJ, Huang Z (2001) Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies. J Biol Chem 276:42826–42833
Zlatopolskiy A, Laurence J (2001) ‘Reverse gear’ cellular movement mediated by chemo-kines. Immunol Cell Biol 79:340–344
Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127
Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998a) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595–599
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Johnson, Z., Frauenschuh, A., Proudfoot, A.E.I. (2003). Targeting the Chemokine System. In: Gordon, S. (eds) The Macrophage as Therapeutic Target. Handbook of Experimental Pharmacology, vol 158. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55742-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-55742-2_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62919-8
Online ISBN: 978-3-642-55742-2
eBook Packages: Springer Book Archive